<?xml version="1.0" encoding="UTF-8"?>
<metadata
  xmlns="http://example.org/myapp/"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://example.org/myapp/ http://example.org/myapp/schema.xsd"
  xmlns:dc="http://purl.org/dc/elements/1.1/"
  xmlns:dcterms="http://purl.org/dc/terms/"><dc:Title>Antiviral drug strategies / edited by Erik De Clercq. [electronic resource]</dc:Title>
<dc:Creator>De Clercq, Erik.</dc:Creator>
<dc:Subject>Antiviral agents Development.</dc:Subject>
<dc:Subject>Antiviral Agents.</dc:Subject>
<dc:Subject>Drug Discovery.</dc:Subject>
<dc:Subject>RS431.A66 A68 2011</dc:Subject>
<dc:Subject>615.7924 22</dc:Subject>
<dc:Description>Includes bibliographical references and index.</dc:Description>
<dc:Description>Print version record.</dc:Description>
<dc:Description>By focusing on general molecular mechanisms of antiviral drugs rather than therapies for individual viruses, this ready reference provides the critical knowledge needed to develop entirely novel therapeutics and to target new viruses. It begins with a general discussion of antiviral strategies, followed by a broad survey of known viral targets, such as reverse transcriptases, proteases, neuraminidases, RNA polymerases, helicases and primases, as well as their known inhibitors. The final section contains several cases studies of recent successful antiviral drug development. Edited by Erik de.</dc:Description>
<dc:Date>2011</dc:Date>
<dc:Type>Text</dc:Type>
<dc:Format>1 online resource (xx, 406 pages) :</dc:Format>
<dc:Identifier>http://onlinelibrary.wiley.com/book/10.1002/9783527635955</dc:Identifier>
<dc:Language>eng</dc:Language>
<dc:Relation>Methods and principles in medicinal chemistry ; v. 50</dc:Relation>
<dc:Relation>Methods and principles in medicinal chemistry ; v. 50.</dc:Relation>
<dc:Relation>Antiviral drug strategies.</dc:Relation>
<dc:Relation>Antiviral drug strategies.</dc:Relation>

</metadata>